Filter Results:
(270)
Show Results For
- All HBS Web
(520)
- News (160)
- Research (270)
- Multimedia (4)
- Faculty Publications (101)
Show Results For
- All HBS Web
(520)
- News (160)
- Research (270)
- Multimedia (4)
- Faculty Publications (101)
Sort by
- 09 Feb 2024
- HBS Case
Slim Chance: Drugs Will Reshape the Weight Loss Industry, But Habit Change Might Be Elusive
Want to Prevent the Next Hospital Bed Crisis? Enlist the SEC How Workplace Wellness Programs Can Give Employees the Energy Boost They Need Can Amazon Remake Health Care? Feedback or ideas to share? Email the... View Details
- September 2022
- Article
Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities
By: Leemore Dafny, Christopher Ody and Teresa Rokos
The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs they manufacture, but manufacturers may donate to independent patient assistance charities and earmark donations... View Details
Keywords: Cost Sharing; Prescription Drugs; Drug Spending; Medicare; Dual Eligibility; Cost; Health Care and Treatment; Philanthropy and Charitable Giving; Pharmaceutical Industry
Dafny, Leemore, Christopher Ody, and Teresa Rokos. "Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities." Health Affairs 41, no. 9 (September 2022).
- 14 Jul 2015
- First Look
First Look: July 14, 2015
current estimates placing financial losses at greater than $3.7 trillion dollars annually. Unfortunately, fraud prevention has been stymied by lack of a clear and comprehensive understanding of its underlying causes and mechanisms. In... View Details
Keywords: Sean Silverthorne
- 2023
- Article
Conduit Incentives: Eliciting Cooperation from Workers Outside of Managers' Control
By: Susanna Gallani
Can managers use monetary incentives to elicit cooperation from workers they cannot reward for their efforts? I study “conduit incentives,” an innovative incentive design, whereby managers influence bonus-ineligible workers’ effort by offering bonus-eligible employees... View Details
Keywords: Organizational Behavior Modification; Peer Monitoring; Persistence Of Performance Improvements; Crowding Out; Implicit Incentives; Compensation; Healthcare; Social Pressure; Image Motivation; Incentives; Motivation; Performance; Behavior; Motivation and Incentives; Compensation and Benefits; Governing Rules, Regulations, and Reforms; Organizational Culture; Health Industry; California
Gallani, Susanna. "Conduit Incentives: Eliciting Cooperation from Workers Outside of Managers' Control." Accounting Review 93, no. 3 (2023): 1–28.
- 10 Apr 2012
- First Look
First Look: April 10
PublicationsHow Will You Measure Your Life? Authors:Clayton M. Christensen, James Allworth, and Karen Dillon Publication:HarperBusiness, forthcoming Abstract In 2010 world-renowned innovation expert Clayton M. Christensen gave a powerful speech to the Harvard... View Details
Keywords: Carmen Nobel
- February 2019 (Revised August 2019)
- Case
KangaTech
By: Karim R. Lakhani, Patrick J. Ferguson, Sarah Fleischer, Jin Hyun Paik and Steven Randazzo
On a warm January afternoon in 2019, Steve Saunders, Dave Scerri, Carl Dilena, and Nick Haslam (see Exhibit 1 for biographies), co-founders of KangaTech, wrapped up the latest round of discussions about the future direction of their sports-technology start-up. Focused... View Details
Keywords: Startup; Technology Commercialization; Prototype; Business Startups; Technological Innovation; Sports; Health; Commercialization; Research and Development; Decision Making; Growth and Development Strategy; Health Industry; Health Industry; Health Industry; Australia
Lakhani, Karim R., Patrick J. Ferguson, Sarah Fleischer, Jin Hyun Paik, and Steven Randazzo. "KangaTech." Harvard Business School Case 619-049, February 2019. (Revised August 2019.)
- 02 Jan 2018
- First Look
First Look at New Research and Ideas, January 3, 2018
stall a company’s scaling efforts. To prevent this from happening, companies must make core processes like recruiting, interviewing, and development a real priority in daily practice. As Aristotle emphasized a long time ago, “Excellence... View Details
Keywords: Sean Silverthorne
- 03 Apr 2009
- Working Paper Summaries
Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings
- 15 Mar 2024
- HBS Case
Let's Talk: Why It's Time to Stop Avoiding Taboo Topics at Work
“We’ve let this fear of litigation prevent us from even acknowledging age at work, to the point that we pretend workers in their 60s or 70s might do their jobs forever.” This silence about age can lead to surprise transitions that are... View Details
Keywords: by Avery Forman
- 05 Nov 2013
- First Look
First Look: November 5
By: Jaeker, Jillian Berry, Anita L. Tucker, and Michael H. Lee Abstract—We exploit an exogenous process change at two emergency departments (EDs) within a health system to test the theory that increasing capacity in a discretionary work... View Details
Keywords: Sean Silverthorne
- 08 Jul 2014
- First Look
First Look: July 8
investigates the effect of pay for performance in firms, yet less is known about the effect of non-financial rewards, especially in organizations that hire individuals to perform tasks with positive social spillovers. We conduct a field experiment in which agents... View Details
Keywords: Carmen Nobel
- August 2017
- Case
Hacking Heroin
By: Mitchell Weiss and Sarah Mehta
"Hacking Heroin" was the first hackathon that Annie Rittgers, founder of Cincinnati-based 17a, had organized or even attended. "There will continue to be a lot of preventable overdose deaths and wasted potential if the opioid crisis continues unabated," she said.... View Details
Keywords: Public Entrepreneurship; Hackathon; Heroin; Opioids; Crowdsourcing; Public Sector; Entrepreneurship; Innovation and Invention; Collaborative Innovation and Invention; Health Pandemics; Health Industry; Health Industry; Ohio; Cincinnati
Weiss, Mitchell, and Sarah Mehta. "Hacking Heroin." Harvard Business School Case 818-010, August 2017.
- November 2017
- Article
A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies
By: S. Balsari, P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough and T. Khanna
Cardiovascular disease is the leading cause of mortality from noncommunicable diseases (NCD) in India. The government’s National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke seeks to increase capacity building, screening,... View Details
Balsari, S., P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough, and T. Khanna. "A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies." Journal of Human Hypertension 31, no. 11 (November 2017): 750–753.
- June 2017 (Revised October 2017)
- Case
Becton Dickinson: Innovation and Growth (A)
By: Raffaella Sadun, Michael Beer and James Weber
In late 2015, CEO Vince Forlenza was reviewing Becton Dickinson’s transformation efforts designed to enable the company to innovate and grow in a changing environment. Becton Dickinson had been a successful medical device company for over 100 years. In recent years,... View Details
Keywords: Transformation; Change Management; Innovation Leadership; Mergers and Acquisitions; Organizational Change and Adaptation; Organizational Culture; Organizational Design; Strategy; Growth and Development Strategy; Health Industry; Health Industry; Health Industry; United States
Sadun, Raffaella, Michael Beer, and James Weber. "Becton Dickinson: Innovation and Growth (A)." Harvard Business School Case 717-419, June 2017. (Revised October 2017.)
- 04 Sep 2001
- Research & Ideas
Is Government Just Stupid? How Bad Decisions Are Made
evaluating business leaders, most people judge them primarily by results: profitability, return to shareholders, innovation and so on. This is the more rational measure of effectiveness. An organization's overall health will generally... View Details
- January 2009
- Case
When Supply is of Public Interest: Roche & Tamiflu
The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu. The Roche group is a 40 billion CHF company consisting of a pharmaceutical division and a diagnostic... View Details
Keywords: Global Strategy; Health Pandemics; Distribution; Logistics; Production; Supply Chain Management; Performance Capacity; Pharmaceutical Industry
Watson, Noel H., Laura Rock Kopczak, and Prashant Yadav. "When Supply is of Public Interest: Roche & Tamiflu." Harvard Business School Case 609-061, January 2009.
- 16 Nov 2021
- HBS Case
How a Company Made Employees So Miserable, They Killed Themselves
unbearable feeling of worthlessness. I am good at nothing, a parasite.” Union surveys found that two-thirds of respondents were stressed and half wanted to quit. Local physicians told the firm’s head of human resources that many employees were suffering from mental... View Details
Keywords: by Michael Blanding
- March 2017
- Case
Cantel Medical
By: John R. Wells and Gabriel Ellsworth
Cantel Medical Corporation provided infection prevention and control products and services for patients, caregivers, and other healthcare providers. In 2016, Cantel generated sales of $665 million and net profits of $60 million, double the levels of five years earlier.... View Details
Keywords: Cantel; Charles Diker; Furniture Industry; Matrix Organization; Acquisition; Mergers and Acquisitions; Business Conglomerates; Business Units; Business Growth and Maturation; Business Organization; For-Profit Firms; Chemicals; Profit; Revenue; Geographic Scope; Multinational Firms and Management; Health; Health Care and Treatment; Business History; Business or Company Management; Goals and Objectives; Growth and Development Strategy; Organizational Structure; Problems and Challenges; Research and Development; Opportunities; Strategy; Adaptation; Business Strategy; Competitive Strategy; Corporate Strategy; Diversification; Expansion; Information Technology; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; United States; New Jersey
Wells, John R., and Gabriel Ellsworth. "Cantel Medical." Harvard Business School Case 717-482, March 2017.
- 18 May 2022
- Research & Ideas
Are Banks the ‘Bad Guys’? Overdraft Fees Are Crushing Low-Income Customers
down accounts, which often happens if a customer fails to repay overdraft fees and other outstanding balances for two months. That black mark can prevent a consumer from opening a bank account elsewhere for up to five years, the authors... View Details
- 27 Feb 2019
- Research & Ideas
The Hidden Cost of a Product Recall
many types of innovation for the firms that experience them.” There’s also a second, less studied wave of damage, as competitors ramp up product development efforts to snap up displaced customers and solidify market share gains. This double whammy makes recall View Details